Free Trial
→ Trump's Law S.1582: $21T Dollar Revolution Coming (From Brownstone Research) (Ad)tc pixel Free IOBT Stock Alerts

IO Biotech (IOBT) Institutional Ownership

IO Biotech logo
$1.00 -0.17 (-14.53%)
Closing price 04:00 PM Eastern
Extended Trading
$1.00 +0.00 (+0.40%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)

Current
Institutional Ownership
Percentage
54.76%
Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$1.57M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$1.38M
Get IOBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IOBT Institutional Buying and Selling by Quarter

IO Biotech Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/19/2025Marex Group plc45,000$63K0.0%N/A0.000%
8/15/2025Bank of America Corp DE1,615,074$2.25M0.0%-2.2%0.000%
8/14/2025NewEdge Advisors LLC24,217$34K0.0%N/A0.037%
8/12/2025XTX Topco Ltd29,189$41K0.0%-42.2%0.000%
5/21/2025Acadian Asset Management LLC30,858$33K0.0%-49.1%0.047%
5/19/2025Jane Street Group LLC23,717$26K0.0%N/A0.036%
5/15/2025Landscape Capital Management L.L.C.400,234$436K0.0%-9.5%0.608%
5/8/2025XTX Topco Ltd50,486$55K0.0%+80.0%0.077%
5/7/2025Dauntless Investment Group LLC681,446$743K0.9%-8.9%1.034%
2/17/2025Bridgeway Capital Management LLC174,000$160K0.0%-12.8%0.264%
2/17/2025Citadel Advisors LLC270,504$249K0.0%N/A0.411%
2/14/2025Dauntless Investment Group LLC747,646$688K0.7%N/A1.135%
2/13/2025XTX Topco Ltd28,040$26K0.0%N/A0.043%
2/13/2025Renaissance Technologies LLC118,800$109K0.0%+22.5%0.180%
2/12/2025Landscape Capital Management L.L.C.442,196$407K0.0%N/A0.671%
1/30/2025Vontobel Holding Ltd.32,667$30K0.0%N/A0.050%
10/24/2024Novo Holdings A S3,354,449$3.52M0.2%-24.3%5.092%
8/20/2024Novo Holdings A S4,429,449$5.18M0.3%-12.9%6.723%
8/15/2024Armistice Capital LLC1,545,000$1.81M0.0%-10.4%2.345%
8/12/2024XTX Topco Ltd26,555$31K0.0%+67.4%0.040%
8/9/2024Renaissance Technologies LLC180,800$212K0.0%+8.1%0.274%
2/15/2024PFM Health Sciences LP2,341,107$4.40M0.3%+73.0%3.554%
2/13/2024Stonepine Capital Management LLC1,666,037$3.13M1.4%-15.7%2.529%
2/13/2024Armistice Capital LLC1,924,000$3.62M0.0%-10.4%2.920%
11/15/2023Armistice Capital LLC2,148,000$3.03M0.0%N/A3.260%
11/14/2023Stonepine Capital Management LLC1,975,308$2.79M0.9%N/A2.998%
11/14/2023Pivotal bioVenture Partners Investment Advisor LLC864,197$1.22M0.5%N/A1.312%
11/8/2023Vivo Capital LLC6,173,439$8.71M1.1%+104.7%9.371%
7/25/2023Summit Trail Advisors LLC43,744$86K0.0%N/A0.152%
2/14/2023RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911%
11/14/2022Psagot Value Holdings Ltd. Israel40,846$111K0.0%N/A0.142%
11/2/2022Victory Capital Management Inc.43,741$119K0.0%N/A0.152%
2/15/2022Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888%
2/15/2022Capital World Investors1,235,000$8.11M0.0%N/A4.286%
2/14/2022Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335%
2/14/2022Novo Holdings A S3,277,932$20.98M1.0%N/A11.376%
(Data available from 1/1/2016 forward)

IOBT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IOBT shares?

During the previous two years, 18 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Vivo Capital LLC ($8.71M), PFM Health Sciences LP ($4.40M), Novo Holdings A S ($3.52M), Stonepine Capital Management LLC ($3.13M), Bank of America Corp DE ($2.25M), Armistice Capital LLC ($1.81M), and Pivotal bioVenture Partners Investment Advisor LLC ($1.22M).Learn more on IO Biotech's institutional investors.

What percentage of IO Biotech's stock is owned by institutional investors?

54.76% of IO Biotech's stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings.

Which institutional investors have been buying IO Biotech's stock?

Of the 14 institutional investors that purchased IO Biotech's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($3.16M), Armistice Capital LLC ($2.15M), Stonepine Capital Management LLC ($1.98M), PFM Health Sciences LP ($987.65K), Pivotal bioVenture Partners Investment Advisor LLC ($864.20K), Dauntless Investment Group LLC ($747.65K), and Landscape Capital Management L.L.C. ($442.20K).

How much institutional buying is happening at IO Biotech?

Institutional investors have bought a total of 1,658,233 shares in the last 24 months. This purchase volume represents approximately $1.57M in transactions.

Which of IO Biotech's major shareholders have been selling company stock?

The following institutional investors have sold IO Biotech stock in the last 24 months: Novo Holdings A S ($1.08M), Dauntless Investment Group LLC ($66.20K), Landscape Capital Management L.L.C. ($41.96K), Bank of America Corp DE ($36.44K), Acadian Asset Management LLC ($29.79K), Bridgeway Capital Management LLC ($25.62K), and XTX Topco Ltd ($21.30K).

How much institutional selling is happening at IO Biotech?

Institutional investors have sold a total of 1,296,315 shares in the last 24 months. This volume of shares sold represents approximately $1.38M in transactions.


Related Companies

This page (NASDAQ:IOBT) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners
Robinhood warning
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...
Stansberry Research | Sponsoredtc pixel
7 market signals flashing red right now
Right now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...
American Alternative | Sponsoredtc pixel
NEW LAW: Congress Approves Setup For Digital Dollar?
Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...
Goldco Precious Metals | Sponsoredtc pixel
If You Keep Cash In A U.S. Bank Account… Read This NOW
The Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...
Banyan Hill Publishing | Sponsoredtc pixel
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...
Angel Publishing | Sponsoredtc pixel
Move $1,000 into this stock before Nov 6
The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...
Altimetry | Sponsoredtc pixel